GPMXY vs CVS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
GPMXY · GRUPO MEXICO SAB DE CV UNSPON ADS EACH REP 2 ORD$26.83 ▲ 33.88%
CVS · CVS Health$80.84 ▲ 1.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- GPMXY +12.1%
- CVS +1.9%
Head to head
| Metric | GPMXY | CVS |
|---|---|---|
| Price | $26.83 | $80.84 |
| Change today | ▲ 33.88% | ▲ 1.00% |
| Market cap | $103.92B | $103.43B |
| Return, 3 months | -9.2% | -14.1% |
| Return, year to date | – | +4.2% |
| Return, 1 year | – | +6.0% |
| P/E (TTM) | 13.2 | 9.4 |
| P/B | 3.9 | 1.3 |
| P/E percentile vs own 5y | – | 7th |
| Dividend yield | 1.69% | 3.29% |
| Revenue growth (YoY, latest qtr) | – | +5.4% |
| Net profit growth (YoY) | – | +154.4% |
| Gross margin | – | 14.2% |
| Operating margin | – | 3.6% |
| Net margin | – | 2.6% |
| Return on equity | – | 14.4% |
| Analyst target vs. price | – | +36.6% |
| Analyst buy share | – | 100% |
| RSI (14) | 59 | 37 |
| 30-day volatility | 97.9% | 51.7% |
| Max drawdown, 1 year | -32.2% | -27.3% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- GPMXY is the largest of the group by market value.
- CVS carries the lowest trailing P/E.
- CVS pays the highest dividend yield.
- CVS has been the calmest stock over the last 30 days.